Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects.

Hsu AP, Donkó A, Arrington ME, Swamydas M, Fink D, Das A, Escobedo O, Bonagura V, Szabolcs P, Steinberg HN, Bergerson J, Skoskiewicz A, Makhija M, Davis J, Foruraghi L, Palmer C, Fuleihan RL, Church JA, Bhandoola A, Lionakis MS, Campbell S, Leto TL, Kuhns DB, Holland SM

Open source

DOI: 10.1182/blood-2018-11-886028
Published: 2019 May 2
Container: Blood
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood-2018-11-886028,
  title = {Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects.},
  author = {Hsu AP and Donkó A and Arrington ME and Swamydas M and Fink D and Das A and Escobedo O and Bonagura V and Szabolcs P and Steinberg HN and Bergerson J and Skoskiewicz A and Makhija M and Davis J and Foruraghi L and Palmer C and Fuleihan RL and Church JA and Bhandoola A and Lionakis MS and Campbell S and Leto TL and Kuhns DB and Holland SM},
  year = {2019},
  journal = {Blood},
  doi = {10.1182/blood-2018-11-886028},
  url = {https://doi.org/10.1182/blood-2018-11-886028}
}

RIS

TY  - JOUR
TI  - Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects.
AU  - Hsu AP
AU  - Donkó A
AU  - Arrington ME
AU  - Swamydas M
AU  - Fink D
AU  - Das A
AU  - Escobedo O
AU  - Bonagura V
AU  - Szabolcs P
AU  - Steinberg HN
AU  - Bergerson J
AU  - Skoskiewicz A
AU  - Makhija M
AU  - Davis J
AU  - Foruraghi L
AU  - Palmer C
AU  - Fuleihan RL
AU  - Church JA
AU  - Bhandoola A
AU  - Lionakis MS
AU  - Campbell S
AU  - Leto TL
AU  - Kuhns DB
AU  - Holland SM
PY  - 2019
JO  - Blood
DO  - 10.1182/blood-2018-11-886028
UR  - https://doi.org/10.1182/blood-2018-11-886028
ER  -

APA

AP, H., A, D., ME, A., M, S., D, F., A, D., O, E., V, B., P, S., HN, S., J, B., A, S., M, M., J, D., L, F., C, P., RL, F., JA, C., A, B., MS, L., S, C., TL, L., DB, K., & SM, H. (2019). Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects.. Blood. https://doi.org/10.1182/blood-2018-11-886028

Source records

pubmed · retrieved 2026-09-27T01:27:46.782Z